Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa

BACKGROUND: The aim of this paper is to evaluate the efficacy and safety of DLBS3233, a novel bioactive fraction derived from Cinnamomum burmanii and Lagerstroemia speciosa, in improving insulin resistance and preserving β-cell performance in patients with impaired glucose tolerance (IGT). PATIENTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Manaf, Asman, Tjandrawinata, Raymond R, Malinda, Desi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820281/
https://www.ncbi.nlm.nih.gov/pubmed/27099473
http://dx.doi.org/10.2147/DDDT.S97568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820281/
https://www.ncbi.nlm.nih.gov/pubmed/27099473
http://dx.doi.org/10.2147/DDDT.S97568

Ejemplares similares